apob

(redirected from Apolipoprotein B)
Also found in: Medical, Acronyms, Wikipedia.

apob

[′ā‚päb]
(meteorology)
An observation of pressure, temperature, and relative humidity taken aloft by means of an aerometeorograph; a type of aircraft sounding.
Mentioned in ?
References in periodicals archive ?
McConathy, "Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B," Clinical Chemistry, vol.
Sniderman, "Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement," Journal of Clinical Lipidology, vol.
Protein fractions of 270, 190, 135 and 100 kDa were found to be apolipoprotein B, alphs-2-macroglobulin, ceruloplasmin and immunoglobulin heavy chain respectively.
Corresponding values for apolipoprotein B were 4, 4, 4, 4, 4, 4, 5, and 6 mg/dL in individuals without diabetes, respectively, and 17, 16, 16, 16, 17, 18, 24, and 26 mg/dL in individuals with diabetes, respectively.
Using multivariate prediction models adjusting for nonlipid risk factors, the apolipoprotein B to apolipoprotein A-I ratio was comparable with other standard lipid level ratios (eg, total cholesterol to HDL) in predicting CHD, but adding the test did not add additional predictive utility.
Apolipoprotein B and AI distributions in the United States, 1988-1991: Results of the National Health and Nutrition Examination Survey III.
Plasma LDL, high-density lipoprotein (HDLe, [HCL.sup.2.C], apolipoprotein A-I and apolipoprotein B levels were measured at the end of each period.
Plasma low-density-lipoprotein (LDL) cholesterol and apolipoprotein B concentrations increased significantly (0.12 +/- 0.65 mmol/L, P less than 0.025; 0.06 +/- 0.12 g/L, P less than 0.0004, respectively) in the group that changed to decaffeinated coffee.
Others have proposed adding measures of apolipoprotein B, apolipoprotein A-I, lipoprotein (a), or lipoprotein-associated phospholipase [A.sub.2] to the current risk prediction formulas to improve risk prediction.
The most pertinent results in the comparison were the significant increase in apolipoprotein B, Ceruloplasmin, apolipoprotein A-I and transthyretin in the sera of patients of CMP compared to healthy subjects.
Apolipoprotein B (apoB), a large amphipathic glycoprotein, plays a central role in human lipoprotein metabolism (2).